Biotechnology Pharmaceutical Market in US 2009-2013 by InfinitiResearch

VIEWS: 61 PAGES: 20

More Info
									Biotechnology Pharmaceutical Market in US

                2009-2013
                                                           Biotechnology Pharmaceutical Market in US




                                                 Table of Contents

1. Introduction...........................................................................................................3
2. Market Size and Forecast.........................................................................................4
3. Market Segmentation.............................................................................................5
4. Market Trends in Biotechnology Pharmaceutical in US.................................................6
5. Market Drivers in Biotechnology Pharmaceutical in US................................................8
6. Market Challenges in Biotechnology Pharmaceutical in US.........................................10
7. Vendors...............................................................................................................12
8. Related Reports in this Series.................................................................................19



                                                   List of Exhibits

Exhibit 2.1: Biotechnology Pharmaceutical in US Market Size and Forecast 2009-2013 (In
$billion)....................................................................................................................4
Exhibit 3.1: US Biotechnology Pharmaceutical Market Segmentation -2009 ......................5




 TechNavio Insights – Book your Analyst Hour

 To become a member of TechNavio TM and enjoy the many benefits of its membership, which include
 one free hour of an analyst’s time for your queries on this report, please visit:
 http://www.technavio.com/user/register




                                                                                                                           2
                                          Biotechnology Pharmaceutical Market in US




1. Introduction


Biotechnology Pharmaceutical refers to drugs, medicines or vaccines developed through
biotechnology such as recombinant DNA technology, combinatorial chemistry, gene therapy,
and monoclonal antibodies. The biotechnology-based drugs or genetically-engineered drugs
are produced by microorganisms such as bacteria or biological substances such as enzymes.




Biotechnology Pharmaceutical represents the fastest growing sector in the Pharmaceutical
market in the US. This could be attributed to the entrants of new generation biotechnology
drugs, which are highly potential and effective in treating a wide range of diseases
including age-related diseases. Further, there is an increasing demand for customized
treatment, as a result of which, many biotechnology pharmaceutical companies are
engaging in the development of drugs targeted at specific genes. Besides, the R&D
spending by pharmaceutical companies has risen steadily.

Of late, the Biotechnology Pharmaceutical market in the US is witnessing many mergers &
acquisitions and joint ventures between big pharmaceutical and small biotechnology
companies. With such consolidations, the big pharmaceutical companies are able to take
the advantage of technical expertise of the smaller companies. On the other hand, the
smaller companies take large equity investments from big pharmaceutical companies for
their research and drug development process as well as to pursue licensing agreements for
the biotechnology drugs.

However, the introduction of new drug in Biotechnology Pharmaceutical market in the US
continues to become more difficult due to extensive research costs and high consumption
of time. Further, the stringent regulatory approval process of new drugs continue to be the
barriers to entry into the US Biotechnology Pharmaceutical market.

This report highlights the scope of the Biotechnology Pharmaceutical market in US, along
with trends, drivers, growth inhibitors and a few major vendors of the market.




                                                                                        3
                                                Biotechnology Pharmaceutical Market in US




2. Market Size and Forecast
According to TechNavio, the market for Biotechnology Pharmaceutical in the US is forecast
to reach $60.1 billion in 2013 from $44.7 billion in 2009; thus, growing at a CAGR of 7.7
percent over the period (Exhibit 2.1).


Exhibit 2.1: Biotechnology Pharmaceutical in US Market Size and Forecast 2009-2013 (In $billion)



                   70

                                                                         60.1
                   60
                                                             55.6
                                                  51.7
                   50                 48.1
                          44.7

                   40


                   30


                   20


                   10


                    0
                          2009        2010       2011        2012        2013



                                                                             Source: TechNavio Analysis


The US is the largest market for Biotechnology 
								
To top